Lou Panaccio - Jun 5, 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: Director
Signature: /s/ Donna Shiroma
Stock symbol: RCEL
Transactions as of: Jun 5, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/6/2024, 08:48 PM
Previous filing: Jun 8, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Award		+9.2K	+24.73%		46.4K	Jun 5, 2024	Direct	F1, F2, F3
holding	RCEL	Common Stock						5.97K	Jun 5, 2024	See footnote	F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCEL	Stock Options (Right to Buy)	Award	$0	+3.94K		$0.00	3.94K	Jun 5, 2024	Common Stock	3.94K	$9.51	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.
F2	Includes unvested RSUs.
F3	Includes 70,460 of the Issuer's CDIs. The Reporting Person holds 70,460 CDIs, which translate into 14,092 of the shares of Common Stock set forth above.
F4	Reflects 29,860 CDIs, which translate into the 5,972 shares of Common Stock set forth above.
F5	These CDIs are held by The Panaccio Superannuation Fund (the "Fund"). The Reporting Person is a director of Tercus Pty Ltd, trustee of the Fund, and is a beneficiary of the Fund. The Reporting Person may be deemed to have shared voting and dispositive power over the CDIs held by the Fund but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein.